Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $4.83 Million - $5.28 Million
21,459 New
21,459 $5.02 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $12.7 Million - $14.7 Million
54,858 Added 425.19%
67,760 $16.5 Million
Q3 2023

Nov 14, 2023

SELL
$254.9 - $283.59 $1.76 Million - $1.95 Million
-6,892 Reduced 34.82%
12,902 $3.34 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $2.67 Million - $2.97 Million
-11,207 Reduced 36.15%
19,794 $5.23 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $2.97 Million - $3.35 Million
12,921 Added 71.47%
31,001 $7.67 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $2.6 Million - $3.06 Million
11,901 Added 192.6%
18,080 $4.6 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $315,314 - $1.63 Million
6,179 New
6,179 $1.38 Million
Q2 2021

Aug 16, 2021

SELL
$232.65 - $254.58 $6.85 Million - $7.49 Million
-29,431 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $45.6 Million - $50.5 Million
-196,521 Reduced 86.97%
29,431 $7.16 Million
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $48.5 Million - $53.8 Million
218,633 Added 2987.2%
225,952 $56.5 Million
Q3 2020

Nov 16, 2020

BUY
$215.77 - $276.76 $253,313 - $324,916
1,174 Added 19.1%
7,319 $1.7 Million
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $25.6 Million - $30.6 Million
-116,293 Reduced 94.98%
6,145 $1.47 Million
Q1 2020

May 15, 2020

BUY
$195.69 - $279.01 $24 Million - $34.2 Million
122,438 New
122,438 $28.1 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $794,578 - $882,451
-3,446 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$217.4 - $246.08 $749,160 - $847,991
3,446 New
3,446 $868,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.